MCL1 and B-cell chronic lymphocytic leukemia: A decrease in the MCL-1 total protein population in CLL cells was observed, and MCL-1-deficient heterogeneous mouse embryonic fibroblasts are highly sensitive to monotherapy and combined therapy (58).